IL17A and acute myeloid leukemia: Inflammatory marker profiles were then compared among these subgroups.<h4>Results</h4>Compared to healthy individuals, the AML group presented significantly increased serum concentrations of IL-4, IL-17A, and TNF-a, while levels of IL-2, IFN-g, and LIF were significantly decreased (P &lt; 0.05).